Wed, November 8, 2023

Robert Driscoll Downgraded (ZNTL) to Hold and Decreased Target to $12 on, Nov 8th, 2023

Robert Driscoll of Wedbush, Downgraded "Zentalis Pharmaceuticals, Inc." (ZNTL) to Hold and Decreased Target from $38 to $12 on, Nov 8th, 2023.

Robert has made no other calls on ZNTL in the last 4 months.



There are 4 other peers that have a rating on ZNTL. Out of the 4 peers that are also analyzing ZNTL, 0 agree with Robert's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Robert


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $46 on, Tuesday, November 7th, 2023
  • Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $36 on, Tuesday, November 7th, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $38 on, Tuesday, November 7th, 2023
  • Derek Archila of "Wells Fargo" Maintained at Buy with Decreased Target to $50 on, Thursday, August 10th, 2023